New Insights into the Roles of Monocytes/Macrophages in Cardiovascular Calcification Associated with Chronic Kidney Disease.

Tytuł:: New Insights into the Roles of Monocytes/Macrophages in Cardiovascular Calcification Associated with Chronic Kidney Disease.
Autorzy:: Hénaut L; EA 7517 MP3CV, CURS, F-80054 Amiens, France. .
Candellier A; EA 7517 MP3CV, CURS, F-80054 Amiens, France. .; Faculty of Medicine, University of Picardie Jules Verne, F-80000 Amiens, France. .; Division of Nephrology, Amiens-Picardie University Hospital, F-80054 Amiens, France. .
Boudot C; EA 7517 MP3CV, CURS, F-80054 Amiens, France. .
Grissi M; EA 7517 MP3CV, CURS, F-80054 Amiens, France. .
Mentaverri R; EA 7517 MP3CV, CURS, F-80054 Amiens, France. .; Department of Biochemistry, Amiens-Picardie University Hospital, F-80054 Amiens, France. .; Faculty of Pharmacy, University of Picardie Jules Verne, F-80000 Amiens, France. .
Choukroun G; EA 7517 MP3CV, CURS, F-80054 Amiens, France. .; Faculty of Medicine, University of Picardie Jules Verne, F-80000 Amiens, France. .; Division of Nephrology, Amiens-Picardie University Hospital, F-80054 Amiens, France. .
Brazier M; EA 7517 MP3CV, CURS, F-80054 Amiens, France. .; Department of Biochemistry, Amiens-Picardie University Hospital, F-80054 Amiens, France. .; Faculty of Pharmacy, University of Picardie Jules Verne, F-80000 Amiens, France. .
Kamel S; EA 7517 MP3CV, CURS, F-80054 Amiens, France. .; Department of Biochemistry, Amiens-Picardie University Hospital, F-80054 Amiens, France. .; Faculty of Pharmacy, University of Picardie Jules Verne, F-80000 Amiens, France. .
Massy ZA; Division of Nephrology, Ambroise Paré University Hospital, APHP, F-92104 Boulogne-Billancourt, France. .; Inserm U1018 -Team 5, CESP, UVSQ, University Paris-Saclay, F-94807 Villejuif, France. .
Źródło:: Toxins [Toxins (Basel)] 2019 Sep 12; Vol. 11 (9). Date of Electronic Publication: 2019 Sep 12.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't; Review
Język:: English
Imprint Name(s):: Original Publication: Basel : MDPI
MeSH Terms:: Macrophages*
Monocytes*
Calcinosis/*immunology
Cardiomyopathies/*immunology
Renal Insufficiency, Chronic/*immunology
Animals ; Humans
References:: Ann Biol Clin (Paris). 2015 May-Jun;73(3):271-87. (PMID: 26069064)
J Biol Chem. 2003 Apr 11;278(15):13333-41. (PMID: 12556469)
Pediatr Obes. 2016 Oct;11(5):375-82. (PMID: 26493023)
Oxid Med Cell Longev. 2016;2016:2795090. (PMID: 27143992)
FASEB J. 2011 Apr;25(4):1314-22. (PMID: 21228221)
J Am Soc Nephrol. 2006 Apr;17(4):1128-34. (PMID: 16481412)
Cardiovasc Hematol Disord Drug Targets. 2014;14(1):34-44. (PMID: 24597598)
Circulation. 1997 Sep 2;96(5):1477-81. (PMID: 9315534)
J Cell Physiol. 2008 Apr;215(1):47-54. (PMID: 17894387)
Circ Res. 2005 Jun 24;96(12):1248-56. (PMID: 15905460)
Toxicol Appl Pharmacol. 2018 Jul 15;351:1-11. (PMID: 29763636)
Nephrol Dial Transplant. 2016 Oct;31(10):1706-12. (PMID: 27445317)
Am J Pathol. 1992 Feb;140(2):301-16. (PMID: 1739124)
Nephrol Dial Transplant. 2002 Sep;17(9):1684-8. (PMID: 12198224)
Angiology. 2016 Feb;67(2):157-67. (PMID: 25904765)
Basic Res Cardiol. 2013 Jul;108(4):368. (PMID: 23800875)
Nat Commun. 2012;3:1329. (PMID: 23271661)
J Am Soc Nephrol. 2004 Aug;15(8):2208-18. (PMID: 15284307)
J Immunol. 2011 Feb 15;186(4):2495-502. (PMID: 21239716)
Sci Rep. 2015 Dec 16;5:18448. (PMID: 26669756)
Nephrol Dial Transplant. 2012 May;27(5):1957-66. (PMID: 22105144)
J Thorac Cardiovasc Surg. 2017 Jun;153(6):1318-1327.e1. (PMID: 28283241)
Circ Res. 2011 Sep 2;109(6):697-711. (PMID: 21885837)
J Cell Sci. 2014 Dec 1;127(Pt 23):4987-93. (PMID: 25453113)
Nephrol Dial Transplant. 2012 Mar;27(3):1169-75. (PMID: 21891772)
Nephrol Dial Transplant. 2009 Mar;24(3):948-55. (PMID: 18852190)
Indian J Nephrol. 2017 Sep-Oct;27(5):359-364. (PMID: 28904431)
Kidney Int. 2004 Jun;65(6):2184-92. (PMID: 15149331)
Circ Res. 2000 Nov 24;87(11):1055-62. (PMID: 11090552)
J Biol Chem. 1993 Oct 15;268(29):22036-41. (PMID: 8408061)
Am J Physiol Renal Physiol. 2007 Sep;293(3):F946-55. (PMID: 17537980)
Atherosclerosis. 2016 Oct;253:15-21. (PMID: 27573734)
Rev Diabet Stud. 2010 Winter;7(4):275-84. (PMID: 21713315)
Kidney Blood Press Res. 2004;27(2):121-6. (PMID: 15051932)
J Cell Sci. 2000 Feb;113 ( Pt 3):377-81. (PMID: 10639325)
Immun Ageing. 2016 Feb 25;13:5. (PMID: 26918023)
J Am Soc Nephrol. 2009 Feb;20(2):381-7. (PMID: 19073826)
Kidney Int. 2011 Jul;80(1):112-8. (PMID: 21451461)
Circulation. 1997 Sep 16;96(6):1755-60. (PMID: 9323058)
J Cell Physiol. 2009 Dec;221(3):572-8. (PMID: 19725047)
J Biol Chem. 2010 Dec 10;285(50):38869-75. (PMID: 20937831)
Toxins (Basel). 2018 Mar 15;10(3):. (PMID: 29543732)
Am J Kidney Dis. 1998 Apr;31(4):607-17. (PMID: 9531176)
Clin J Am Soc Nephrol. 2010 Feb;5(2):227-34. (PMID: 20056757)
PLoS One. 2017 Jan 13;12(1):e0169024. (PMID: 28085888)
Antioxid Redox Signal. 2011 Jun 15;14(12):2337-46. (PMID: 21235354)
Artif Organs. 2017 Sep;41(9):803-809. (PMID: 28524237)
Nephron. 1991;57(3):283-7. (PMID: 2017267)
Am J Kidney Dis. 2008 Sep;52(3):519-30. (PMID: 18514987)
Circ Res. 2003 Aug 22;93(4):311-20. (PMID: 12881478)
J Clin Invest. 2007 Apr;117(4):902-9. (PMID: 17364026)
Exp Cell Res. 1998 Jul 10;242(1):128-37. (PMID: 9665810)
Exp Mol Pathol. 2015 Dec;99(3):654-62. (PMID: 26551087)
Eur J Cardiothorac Surg. 2015 Sep;48(3):e20-9. (PMID: 26273067)
Circ Res. 2012 Aug 17;111(5):575-84. (PMID: 22753077)
Virchows Arch. 1998 Dec;433(6):559-65. (PMID: 9870690)
Cardiovasc Res. 2012 Oct 1;96(1):130-9. (PMID: 22822101)
Semin Dial. 2009 Jul-Aug;22(4):340-5. (PMID: 19708978)
J Am Coll Cardiol. 2012 Oct 16;60(16):1512-20. (PMID: 22999728)
J Am Soc Hypertens. 2016 Jul;10(7):559-569.e3. (PMID: 27247108)
Circulation. 2009 Nov 10;120(19):1893-902. (PMID: 19858416)
Artif Organs. 2012 Oct;36(10):886-93. (PMID: 22845695)
J Clin Hypertens (Greenwich). 2014 Jun;16(6):424-8. (PMID: 24739097)
PLoS One. 2017 Mar 31;12(3):e0174998. (PMID: 28362852)
Circ Res. 2011 Apr 29;108(9):1112-21. (PMID: 21393578)
Int J Cardiol. 2013 Oct 3;168(3):2242-7. (PMID: 23453445)
J Cardiovasc Med (Hagerstown). 2011 Feb;12(2):96-101. (PMID: 20625307)
Vasc Med. 2015 Dec;20(6):527-33. (PMID: 26324151)
Atherosclerosis. 2009 Jul;205(1):55-62. (PMID: 19118829)
Am J Physiol Cell Physiol. 2011 Jan;300(1):C210-20. (PMID: 20881235)
Eur J Clin Invest. 2015 Dec;45(12):1333-40. (PMID: 26519693)
Blood Purif. 2013;36(3-4):287-94. (PMID: 24496201)
J Mol Cell Cardiol. 2005 Aug;39(2):389-93. (PMID: 15893766)
Pol Arch Intern Med. 2018 Mar 29;128(3):157-165. (PMID: 29600966)
Nat Rev Immunol. 2008 Dec;8(12):958-69. (PMID: 19029990)
PLoS One. 2013;8(4):e60904. (PMID: 23577176)
Clin Transl Med. 2015 Feb 14;4:5. (PMID: 25852821)
Circulation. 2002 Feb 5;105(5):650-5. (PMID: 11827934)
J Atheroscler Thromb. 2016 Aug 1;23(8):960-75. (PMID: 26860885)
PLoS One. 2015 Nov 10;10(11):e0142335. (PMID: 26555788)
Kidney Res Clin Pract. 2013 Dec;32(4):147-52. (PMID: 26877933)
N Engl J Med. 2000 May 18;342(20):1478-83. (PMID: 10816185)
Arterioscler Thromb Vasc Biol. 2017 Jul;37(7):e82-e91. (PMID: 28473436)
Nephrol Dial Transplant. 2006 May;21(5):1161-6. (PMID: 16490741)
Nephrol Dial Transplant. 2018 Jan 1;33(1):34-43. (PMID: 28992224)
Am J Physiol Cell Physiol. 2016 May 15;310(10):C788-99. (PMID: 26936458)
Matrix Biol. 2000 Jul;19(3):203-9. (PMID: 10936445)
Clin J Am Soc Nephrol. 2008 Sep;3(5):1289-95. (PMID: 18562597)
J Am Coll Cardiol. 2006 Jun 6;47(11):2141-51. (PMID: 16750677)
PLoS One. 2016 Feb 29;11(2):e0149276. (PMID: 26925780)
Thromb Haemost. 2011 Nov;106(5):757-62. (PMID: 21901241)
Contrib Nephrol. 2011;171:57-61. (PMID: 21625090)
J Leukoc Biol. 2013 Jun;93(6):837-45. (PMID: 23362306)
Adv Skin Wound Care. 2019 May;32(5):205-215. (PMID: 31008757)
Dis Markers. 2013;34(4):229-35. (PMID: 23396289)
Toxicol Appl Pharmacol. 2014 Jan 15;274(2):191-9. (PMID: 24161588)
Sci Rep. 2015 Sep 11;5:13886. (PMID: 26358827)
Kidney Int. 2005 Jul;68(1):173-8. (PMID: 15954906)
Kidney Int. 2007 Sep;72(6):709-15. (PMID: 17597697)
Am J Physiol Renal Physiol. 2016 Mar 15;310(6):F511-7. (PMID: 26764205)
J Cardiovasc Dev Dis. 2015 Apr 15;2(2):31-47. (PMID: 29371511)
Biophys J. 2010 Dec 15;99(12):3986-95. (PMID: 21156141)
Nat Rev Nephrol. 2012 Mar 13;8(6):362-9. (PMID: 22410492)
Kidney Int. 2011 Feb;79(4):414-22. (PMID: 20944546)
Cardiovasc Pathol. 2007 Jan-Feb;16(1):29-37. (PMID: 17218212)
J Cardiovasc Transl Res. 2019 Jun;12(3):204-210. (PMID: 30414068)
Circ Res. 2015 Apr 10;116(8):1312-23. (PMID: 25711438)
Pediatr Nephrol. 2019 Aug 19;:null. (PMID: 31428929)
J Biol Chem. 2010 Sep 24;285(39):29925-31. (PMID: 20663885)
Arterioscler Thromb Vasc Biol. 2017 Feb;37(2):179-180. (PMID: 28122774)
J Bone Miner Res. 2012 Nov;27(11):2399-412. (PMID: 22692895)
Semin Dial. 2016 Sep;29(5):333-7. (PMID: 27174444)
BMC Cardiovasc Disord. 2010 Apr 21;10:19. (PMID: 20409295)
J Cell Physiol. 2019 Feb 25;:null. (PMID: 30805930)
Cell Mol Immunol. 2006 Apr;3(2):151-4. (PMID: 16696903)
Trends Pharmacol Sci. 2004 Jun;25(6):294-7. (PMID: 15165742)
Cardiovasc Res. 2014 Feb 1;101(2):256-65. (PMID: 24217682)
Cardiovasc Res. 1997 Dec;36(3):293-7. (PMID: 9534848)
Metabolism. 2017 Sep;74:32-40. (PMID: 28764846)
Nephrol Dial Transplant. 2011 Apr;26(4):1327-39. (PMID: 21148030)
Clin J Am Soc Nephrol. 2011 Oct;6(10):2374-83. (PMID: 21817129)
Hemodial Int. 2017 Jul;21(3):348-358. (PMID: 27670395)
Kidney Int. 1999 Feb;55(2):648-58. (PMID: 9987089)
Atherosclerosis. 2010 Aug;211(2):579-83. (PMID: 20427046)
Biochem Biophys Res Commun. 1998 May 19;246(2):501-6. (PMID: 9610391)
Bone. 2007 May;40(5):1370-7. (PMID: 17320497)
PLoS One. 2016 May 31;11(5):e0156686. (PMID: 27243975)
Bone. 2002 Jan;30(1):26-31. (PMID: 11792561)
Int J Nephrol. 2014;2014:164125. (PMID: 24829798)
J Vasc Res. 2012;49(6):510-21. (PMID: 22948607)
Blood. 2010 Oct 21;116(16):e74-80. (PMID: 20628149)
Nephrol Dial Transplant. 2012 Oct;27(10):3823-8. (PMID: 22273664)
Kidney Int. 2016 Feb;89(2):439-49. (PMID: 26466319)
Aging (Albany NY). 2019 Jun 26;11(12):4274-4299. (PMID: 31241466)
Circ Res. 2016 Feb 19;118(4):653-67. (PMID: 26892964)
J Bone Miner Res. 1997 Dec;12(12):1959-70. (PMID: 9421228)
J Am Soc Nephrol. 2013 Dec;24(12):1981-94. (PMID: 24009240)
Atherosclerosis. 2008 Jan;196(1):98-105. (PMID: 17350022)
Proc Natl Acad Sci U S A. 2017 May 23;114(21):5485-5490. (PMID: 28484006)
J Am Coll Cardiol. 2019 Jan 29;73(3):305-314. (PMID: 30678761)
Hypertension. 2001 Oct;38(4):938-42. (PMID: 11641313)
Nat Med. 2007 Oct;13(10):1176-84. (PMID: 17828273)
Circ Res. 2017 Jun 23;121(1):5-7. (PMID: 28642321)
Nephrol Dial Transplant. 2012 Dec;27 Suppl 4:iv17-21. (PMID: 23258805)
J Am Soc Nephrol. 2012 Jul;23(7):1258-70. (PMID: 22626821)
Medicine (Baltimore). 2017 Apr;96(14):e6565. (PMID: 28383435)
Circ Res. 2013 Jun 21;113(1):72-7. (PMID: 23616621)
Diabetes. 2014 Dec;63(12):4275-90. (PMID: 25008174)
Blood Purif. 2011;31(4):281-8. (PMID: 21242682)
Arterioscler Thromb Vasc Biol. 2007 Apr;27(4):826-32. (PMID: 17255534)
Nephrol Dial Transplant. 2009 May;24(5):1429-35. (PMID: 19059932)
Nutr Metab Cardiovasc Dis. 2015 Feb;25(2):187-94. (PMID: 25315669)
Sci Rep. 2018 Sep 18;8(1):13964. (PMID: 30228352)
J Cell Biochem. 2012 Mar;113(3):1034-43. (PMID: 22213462)
Nephrol Dial Transplant. 2012 Jun;27(6):2176-81. (PMID: 22140126)
J Cell Biochem. 2006 Aug 1;98(5):1150-62. (PMID: 16514665)
J Ren Nutr. 2012 Jan;22(1):86-9. (PMID: 22200421)
Biochem Biophys Res Commun. 2011 Sep 30;413(3):436-41. (PMID: 21907184)
Eur J Ophthalmol. 2017 May 11;27(3):e99-e103. (PMID: 28315516)
Clin Exp Nephrol. 2013 Jun;17(3):365-71. (PMID: 23100178)
Toxicol Lett. 2016 Mar 14;245:24-30. (PMID: 26784855)
Nephrol Dial Transplant. 2018 Apr 1;33(4):574-585. (PMID: 29228352)
Biochem Biophys Res Commun. 2017 Sep 9;491(1):154-158. (PMID: 28711495)
Kidney Int. 2015 Jun;87(6):1092-4. (PMID: 26024026)
Infect Immun. 1998 Jun;66(6):2782-90. (PMID: 9596748)
Am J Pathol. 2017 Jun;187(6):1413-1425. (PMID: 28431214)
J Pathol. 1998 May;185(1):10-7. (PMID: 9713354)
Toxins (Basel). 2017 Mar 23;9(4):. (PMID: 28333114)
Nature. 2011 May 19;473(7347):317-25. (PMID: 21593864)
Expert Opin Ther Targets. 2016;20(1):89-105. (PMID: 26788590)
Circ Res. 2016 Nov 11;119(11):1226-1241. (PMID: 27992360)
Atherosclerosis. 2018 Mar;270:193-195. (PMID: 29395099)
Clin J Am Soc Nephrol. 2009 Oct;4(10):1551-8. (PMID: 19696217)
Nephrol Dial Transplant. 2018 Apr 1;33(4):543-548. (PMID: 29420799)
Eur Heart J. 2011 Jan;32(1):84-92. (PMID: 20943670)
Biomark Res. 2014 Jan 07;2(1):1. (PMID: 24398220)
Circulation. 2011 Oct 18;124(16):1783-91. (PMID: 22007101)
Kidney Int. 2009 May;75(9):890-7. (PMID: 19145240)
Arthritis Rheumatol. 2016 Jun;68(6):1531-9. (PMID: 26748935)
Thromb Haemost. 2017 Dec;117(12):2346-2355. (PMID: 29212122)
Nephrology (Carlton). 2008 Dec;13(6):480-6. (PMID: 18518940)
Front Immunol. 2014 Nov 28;5:614. (PMID: 25506346)
Cell Physiol Biochem. 2015;35(6):2483-500. (PMID: 25967877)
Kidney Int. 2008 Mar;73(5):622-9. (PMID: 18160960)
J Clin Invest. 2000 May;105(9):1299-305. (PMID: 10792005)
Nat Rev Rheumatol. 2012 Jan 31;8(4):195-202. (PMID: 22293756)
J Bone Miner Res. 2006 Mar;21(3):484-90. (PMID: 16491297)
Traffic. 2011 Jul;12(7):912-24. (PMID: 21466643)
Blood Purif. 2010;30(4):277-87. (PMID: 21079396)
PLoS One. 2018 Oct 24;13(10):e0205831. (PMID: 30356327)
Toxins (Basel). 2015 Aug 14;7(8):3155-66. (PMID: 26287243)
Cell Physiol Biochem. 2015;36(1):358-72. (PMID: 25967974)
Am J Kidney Dis. 2009 Sep;54(3):478-89. (PMID: 19359080)
Adv Immunol. 2010;108:1-20. (PMID: 21056727)
Int Urol Nephrol. 2012 Dec;44(6):1731-44. (PMID: 22965378)
Circ Res. 2011 May 27;108(11):1381-91. (PMID: 21617135)
J Bone Miner Res. 2003 Oct;18(10):1872-81. (PMID: 14584898)
Atherosclerosis. 2017 Apr;259:60-67. (PMID: 28292668)
Arterioscler Thromb Vasc Biol. 2011 Jun;31(6):1387-96. (PMID: 21454810)
Calcif Tissue Int. 2011 Mar;88(3):169-78. (PMID: 21161195)
Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):321-6. (PMID: 19948844)
Nature. 2002 Jul 11;418(6894):191-5. (PMID: 12110890)
Kidney Int. 2002 Feb;61(2):609-14. (PMID: 11849403)
Circ Res. 2017 Jun 23;121(1):19-30. (PMID: 28438779)
Circulation. 2019 Jan 2;139(1):78-96. (PMID: 30586693)
Nature. 2012 Dec 6;492(7427):123-7. (PMID: 23143333)
J Cardiovasc Transl Res. 2017 Feb;10(1):27-34. (PMID: 28097522)
Arterioscler Thromb Vasc Biol. 2014 Sep;34(9):2120-7. (PMID: 25060791)
Nat Rev Immunol. 2005 Dec;5(12):953-64. (PMID: 16322748)
J Am Soc Nephrol. 2005 Feb;16(2):520-8. (PMID: 15615819)
N Engl J Med. 2012 Dec 27;367(26):2482-94. (PMID: 23121374)
J Rheumatol. 2019 Sep;46(9):1141-1150. (PMID: 30824640)
Biochem Biophys Res Commun. 2012 Aug 17;425(1):39-44. (PMID: 22820183)
FASEB J. 2013 Nov;27(11):4355-65. (PMID: 23901071)
Kobe J Med Sci. 2017 Oct 16;63(2):E45-E50. (PMID: 29434174)
J Adv Res. 2017 Sep;8(5):529-536. (PMID: 28748118)
Immunobiology. 2018 Aug - Sep;223(8-9):526-535. (PMID: 29605258)
N Engl J Med. 2005 May 12;352(19):1959-66. (PMID: 15888696)
J Vasc Res. 2004 Mar-Apr;41(2):193-201. (PMID: 15031603)
Nephrol Dial Transplant. 2011 May;26(5):1516-22. (PMID: 20923925)
Contributed Indexing:: Keywords: cardiovascular calcification; chronic kidney disease; macrophages; monocytes; uraemic toxins
Entry Date(s):: Date Created: 20190925 Date Completed: 20201002 Latest Revision: 20201002
Update Code:: 20240105
PubMed Central ID:: PMC6784181
DOI:: 10.3390/toxins11090529
PMID:: 31547340
: Czasopismo naukowe

Pełny tekst

Cardiovascular disease (CVD) is an important cause of death in patients with chronic kidney disease (CKD), and cardiovascular calcification (CVC) is one of the strongest predictors of CVD in this population. Cardiovascular calcification results from complex cellular interactions involving the endothelium, vascular/valvular cells (i.e., vascular smooth muscle cells, valvular interstitial cells and resident fibroblasts), and monocyte-derived macrophages. Indeed, the production of pro-inflammatory cytokines and oxidative stress by monocyte-derived macrophages is responsible for the osteogenic transformation and mineralization of vascular/valvular cells. However, monocytes/macrophages show the ability to modify their phenotype, and consequently their functions, when facing environmental modifications. This plasticity complicates efforts to understand the pathogenesis of CVC-particularly in a CKD setting, where both uraemic toxins and CKD treatment may affect monocyte/macrophage functions and thereby influence CVC. Here, we review (i) the mechanisms by which each monocyte/macrophage subset either promotes or prevents CVC, and (ii) how both uraemic toxins and CKD therapies might affect these monocyte/macrophage functions.
Competing Interests: Z. A. Massy reports grants for CKD REIN and other research projects from Amgen, Baxter, Fresenius Medical Care, GlaxoSmithKline, Merck Sharp and Dohme-Chibret, Sanofi-Genzyme, Lilly, Otsuka and the French government, as well as fees and grants to charities from Amgen, and Sanofi-Genzyme. These sources of funding are not necessarily related to the content of the present manuscript.

Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Informacja